ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 3242

Identification and Functional Characterization of TNIP1 Causal Variants Associated with Systemic Lupus Erythematosus

Satish Pasula1, Mandi Wiley1, Ying-yu Wu1, Ajay Nair1, Jaanam Gopalakrishnan2 and Patrick M. Gaffney1, 1Arthritis and Clinical Immunology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, 2Department of Pathology, University of Oklahoma Health Sciences Center, Oklahoma City, OK

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: epigenetics and genetics, SLE

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Wednesday, November 16, 2016

Title: Systemic Lupus Erythematosus – Human Etiology and Pathogenesis II

Session Type: ACR Concurrent Abstract Session

Session Time: 11:00AM-12:30PM

Background/Purpose: Systemic lupus erythematosus (SLE) is a chronic autoimmune disease characterized by autoantibody production and dysregulated interferon responses. Genome-wide association studies (GWAS) have identified more than 80 susceptibility or risk genes/loci associated with SLE and other autoimmune diseases, including TNFAIP3 interacting protein 1 (TNIP1). TNIP1 encodes the adaptor protein ABIN1, which functions in the immune system by restricting NF-κB signaling. Previous fine mapping of the TNIP1 locus demonstrated significant associations with SLE and single nucleotide polymorphisms (SNPs) that are carried on two independent risk haplotypes within TNIP1. Both risk haplotypes demonstrated reduced expression of TNIP1 mRNA and ABIN1 protein. In this work we characterize associated SNPs in TNIP1 and identify candidate causal SNPs that influence hypomorphic expression of TNIP1.

Methods: Eleven TNIP1 SNPs from both SLE risk haplotypes which have lower binding scores (RegulomeDB) were selected for electrophoretic mobility shift assays (EMSA) to evaluate whether SLE risk alleles affect binding of nuclear protein complexes extracted from different immune cells that were treated with and without PMA/Ionomycin (P/I) in 3 independent EMSA tests. Affinity DNA pull-down assay and Western blotting (WB) was performed to identify proteins bound to rs10036748 probe.

Results: EMSAs using probes containing non-risk and risk alleles of 11 SLE associated SNPs in the TNIP1 locus identified 3 variants with reduced binding of nuclear proteins to the SLE risk allele from the Jurkat T cell line, EBV transformed B cells and the monocytoid cell line, THP-1. Five of the 11 variants demonstrated P/I stimulation dependency of which 2 variants showed decreased binding to the risk allele and 3 variants showed increased binding to the risk allele. Interestingly, 3 TNIP1 SNPs showed increased binding of nuclear proteins to the risk-allele under resting conditions; one of these was P/I stimulus dependent. Overall, the SNPs carried on both TNIP1 SLE risk haplotypes demonstrated complex binding activity with the Jurkat T cell line having the most activity (8 of 11 SNPs showing differential binding). To begin verifying the identity of the nuclear proteins present in the EMSA, we used affinity pull-down followed by WB for the rs10036748 variant which had reduced binding of nuclear proteins to risk-allele in all 3 cell types. Based on ENCODE defined transcription factor binding, we confirm that early growth response 1 and NF-κB subunit, RelA are associated with this variant DNA and reduced with the risk allele of rs10036748.

Conclusion: Functional analyses of SNPs in TNIP1 SLE risk haplotypes suggested a complex regulation at TNIP1 locus. The association of transcriptional protein complexes at these SNPs is highly regulated showing cell type specificity, stimulation dependency and allele specific binding. The regulatory insights gained through in-vitro assays will better direct us to further separate and characterize individual SLE associated TNIP1 variants in-vivo to decipher molecular mechanisms and cell states by which TNIP1 risk haplotypes contribute to SLE pathogenesis.


Disclosure: S. Pasula, None; M. Wiley, None; Y. Y. Wu, None; A. Nair, None; J. Gopalakrishnan, None; P. M. Gaffney, None.

To cite this abstract in AMA style:

Pasula S, Wiley M, Wu YY, Nair A, Gopalakrishnan J, Gaffney PM. Identification and Functional Characterization of TNIP1 Causal Variants Associated with Systemic Lupus Erythematosus [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/identification-and-functional-characterization-of-tnip1-causal-variants-associated-with-systemic-lupus-erythematosus/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/identification-and-functional-characterization-of-tnip1-causal-variants-associated-with-systemic-lupus-erythematosus/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology